Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer

Scandinavian Journal of Urology and Nephrology

Volumn 42, Issue 5, 2008, Pages 417-421

  Jancke, G ^a   Damm, O ^a   Rosell, J ^a   Jahnson, S ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bladder cancer; Local recurrence; Risk factors

Indexed keywords

ANTINEOPLASTIC AGENT; BCG VACCINE;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER RECURRENCE; CANCER SURGERY; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BCG VACCINE; BIOPSY; CARCINOMA, TRANSITIONAL CELL; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; CYSTOSCOPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, MULTIPLE PRIMARY; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; TUMOR BURDEN; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 54249090787     PISSN: 00365599     EISSN: 16512065     Source Type: Journal    
DOI: 10.1080/00365590802016302     Document Type: Article

References (26)

1. Kurth KH, Bouffioux C, Sylvester R, van der Meijden AP, Oosterlinck W, Brausi M. Treatment of superficial bladder tumors: achievements and needs. The EORTC Genitourinary Group. Eur Urol 2000;37(Suppl 3):1-9.
2. Aso Y, Anderson L, Soloway M, Bouffioux C, Chisholm G, Debruyne F, et al. Prognostic factors in superficial bladder cancer. Prog Clin Biol Res 1986;221:257-69.
3. Mulders PFA, Meyden APM, Doesburg WH, Oosterhof GON, Debruyne FMJ. Prognostic factors in pTa-pT1 superficial bladder tumours treated with intravesical instillations. Br J Urol 1994;73:403-8.
4. Millan-Rodriguez F, Chechile-Toniolo G, Salvador-Bayarri J, Palou J, Vicente-Rodriguez J. Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol 2000;163:73-8.
5. Ali-El-Dein B, Sarhan O, Hinev A, Ibrahiem EL-HI, Nabeeh A, Ghoneim MA. Superficial bladder tumours: analysis of prognostic factors and construction of a predictive index. Br J Urol 2003;92:393-9.
6. Dalesio O, Schulman CC, Sylvester R, De Pauw M, Robinson M, Denis L, et al. Prognostic factors in superficial bladder tumours. A study of the European Organisation for Research on Treatment of Cancer: Genitourinary Tract Cancer Cooperative Group. J Urol 1983;129:730-3.
7. Witjes JA, Kiemeney LALM, Verbeek ALM, Heijbroek RP, Debruyne FMJ. Random bladder biopsies and the risk of recurrent superficial bladder cancer: a prospective study in 1026 patients. World J Urol 1992;10:231-4.
8. Parmar MKB, Freedman LS, Hargreave TB, Tolley DA. Prognostic factors for recurrence and followup policies in the treatment of superficial bladder cancer: report from the British Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party). J Urol 1989;142:284-8.
9. Bergkvist A, Ljungkvist A, Moberger G. Classification of bladder tumours based on a cellular pattern. Acta Chir Scand 1965;130:371-8.
10. Sobin LH, Wittekind C. TNM, classification of malignant tumours, 6th ed. New York: Wiley-Liss; 2002. p. 199-202.
11. Cox DR. Regression models and life tables. J R Stat Soc B 1972;34:187.
12. Loening S, Narayana A, Yoder L, Slymen D, Penig G, Clup D. Analysis of bladder tumour recurrence in 178 patients. Urology 1980;16:137-41.
13. Raitanen MP, Tammela TL. Impact of tumour grade, stage, number and size, smoking habits and sex on the recurrence rate and disease-free interval in patients with transitional cell carcinoma of the bladder. Ann Chir Gynecol 1995;84:37-41.
14. Shinka T, Matsumoto M, Ogura H, Hirano A, Ohkawa T. Recurrence of primary superficial bladder cancer treated with prophylactic intravesical Tokyo 172 bacillus Calmette-Guerin: a long-term follow-up. Int J Urol 1997;4:139-43.
15. Narayna AS, Loening SA, Slymen DJ, Culp DA. Bladder cancer: factors affecting survival. J Urol 1994;73:403-7.
16. Kurth KH, Denis L, Bouffioux C, Sylvester R, Debruyne M, Pavone-Macaluso, Oosterlinck W. Factors affecting recurrence and progression in superficial bladder tumours. Eur J Cancer 1995;31A:1840-6.
17. Allard P, Bernard P, Fradet Y, Tetu B. The early clinical course of primary Ta and T1 bladder cancer: a proposed prognostic index. Br J Urol 1998;81:692-8.
18. Zieger K,Wolf H, Olsen PR, Hojgaard K. Long-term follow-up of noninvasive bladder tumours (stage Ta): recurrence and progression. BJU Int 2000;85:824-8.
19. Sakai I, Miyake H, Harada K, Hara I, Inoue TA, Fujisawa M. Analysis of factors predicting intravesical recurrence of superficial transitional carcinoma of the bladder without concomitant carcinoma in situ. Int J Urol 2006;13:1389-92.
20. Heney NM, Nocks BN, Daly JJ, Prout GR Jr, Newall JB, Griffin PP, et al. Ta and T1 bladder cancer: location, recurrence and progression. Br J Urol 1982;54:152-7.
21. Heney NM, Ahmed S, Flanagan MJ, Frable W, Corder MP, Hafermann MD, Hawkins IR, for the National Bladder Cancer Collaborative Group. Superficial bladder cancer: progression and recurrence. J Urol 1983;130:1083-6.
22. Lutzeyer W, Rubben H, Dahm H. Prognostic parameters in superficial bladder cancer: an analysis of 315 cases. J Urol 1982;127:250-2.
23. Morgan JDT, Bowsher W, Griffiths DFR, Matthews PN. Rationalisation of follow-up in patients with non-invasive bladder tumours. A preliminary report. Br J Urol 1991;67:158-61.
24. Kiemeny LALM, Witjes JA, Heijbroek RP, Verbeek AI, Debruyne FM. Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer. J Urol 1993;150:60-4.
25. Kwak C, Ku JH, Park JY, Lee E, Lee SE, Lee C. Initial tumor stage and grade as a predictive factor for recurrence in patients with stage T1 grade 3 bladder cancer. J Urol 2004;171:149-52.
26. Jahnson S, Wiklund F, Duchek M, Mestad O, Rintala E, Hellsten S, Mahlström P-U. Results of second-look after primary resection of T1 tumour of the urinary bladder. Scand J Urol 2005;39:206-10.